Correction to: npj Digital Medicine 10.1038/s41746-024-01011-0, published online 26 January 2024
The authors would like to correct the competing interests statement for transparency. The original competing interests statement stated that ‘B.M.R.S. and O.L. are co-founders of VRx Health. The remaining authors declare no competing interests.’ The new competing interests statement is as follows: ‘This research was supported through internal funding at Cedars-Sinai Medical Center. After initial funding VRx Health was formed for the purpose of commercializing Cedars-Sinai VR technology. Authors B.M.R.S. and O.L. are co-founders of VRx Health. At the time of acceptance, VRx Health did not own the license to XAIA. The XAIA technology was exclusively licensed from Cedars-Sinai to VRx Health on 23rd January 2024, after acceptance of this manuscript for publication. The remaining authors declare no competing interests.’ The original article has been corrected.